Anteris Technologies Global revenue was $2.70M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $536.1k, down 30.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVR annual revenue was $2.7M, with -1.2% growth year-over-year.
AVR past revenue growth
How has AVR's revenue growth performed historically?
Anteris Technologies Global (NASDAQ: AVR) reported Q4 2024 revenue of $536.11 thousand up 1.51% year over year. In the same quarter last year, Anteris Technologies Global's revenue was $544.34 thousand.
What was Anteris Technologies Global's revenue in 2024?
Anteris Technologies Global's annual revenue for the twelve months ending Dec 31, 2024 was $2.70 million, a 1.17% decrease year over year.
How much does Anteris Technologies Global make in a day?
Based on Anteris Technologies Global annual revenue for the past two years, AVR makes an average of $7,449.32 per day.
What was Anteris Technologies Global's annual revenue growth in the past year?
As of Q2 2025, Anteris Technologies Global's revenue has grown -1.17% year over year. This is 10.91 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 9.74%. Anteris Technologies Global's revenue in the past year totaled $2.70 million.
How much does Anteris Technologies Global make in a year?
Anteris Technologies Global's revenue by year for the past two years is:
Anteris Technologies Global's revenue for the twelve months ending Dec 31, 2024 was $2.70 million, a 1.17% decrease year over year.
Anteris Technologies Global's annual revenue for Dec 31, 2023 was $2.74 million, a 14.55% decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.